Sexually Transmitted Diseases (STD) Testing Market Is Expected to Garner $150.44 Billion By 2030, Registering at A CAGR of 5.1% By 2030

Allied Market Research recently published a report, titled, "Sexually Transmitted Diseases (STD) Testing Market by Disease Type (Chlamydia, Gonorrhea, Herpes Simplex Virus, Syphilis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), and Other Diseases) and Location of Testing (Laboratory Testing, and Point-of-care (POC) Testing): Global Opportunity Analysis and Industry Forecast, 2021-2030". As per the report, the global sexually transmitted diseases (STD) testing industry was accounted for $91.44 billion in 2030, and is expected to garner $150.44 billion by 2030, registering at a CAGR of 5.1% from 2021 to 2030.

♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.alliedmarketresearch.com/request-sample/385

However, there is a social stigma associated with patients visiting specialized sexually transmitted disease clinics that prevent patients from being diagnosed with sexually transmitted diseases. In addition, a large percentage of STD patients are located in geographic areas out of reach, significantly limiting the diagnosis of STDs. These factors should hold back the growth of the STD test market.

The growth of the STD market is largely driven by the high and increasing prevalence of STDs such as chlamydia, syphilis, and gonorrhea. In addition, the implementation of national screening programs to improve and increase the detection of STDs in many regions such as the US, the UK and Canada, and support for the reimbursement of STD screening tests further support the growth of sexually transmitted diseases (STD) test market. However, there is a social stigma associated with patients attending STD clinics that prevents patients from identifying STDs. In addition, a large number of patients infected with STDs are based in inaccessible areas, which greatly hinders the diagnosis of STDs. These factors are expected to hinder the growth of the STD testing market.

Major Key Market Players Are -

Abbott laboratories,
Becton Dickinson Company,
BioMérieux, Inc.,
Bio-Rad Laboratories, Inc.,
Danaher Corporation,
Diasorin Molecular LLC,
Hologic, Inc.,
Orasure Technologies, Inc.,
Roche Holding AG and
Thermo Fisher Scientific Inc.

♦ 𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲:
https://www.alliedmarketresearch.com/purchase-enquiry/385

Currently, STD is considered as one of the most serious health problems in the world. Chlamydia, gonorrhea, and herpes simplex virus are some of the most common STDs. The STD testing market has grown significantly in recent years due to the high prevalence of major STDs in the world and thus the increasing need for STD detection. However, limited access to STD testing among the majority of the population in developing countries is expected to hinder the growth of the sexually transmitted disease (STD) testing market.

The gonorrhea segment will manifest the highest until 2030

By disease type, the gonorrhea segment is expected to exhibit the highest CAGR of 7.3% over the forecast period. However, the Chlamydia testing segment dominated the market in 2020, accounting for more than a quarter of the market, due to a lack of awareness of sexually transmitted diseases among the population and a lack of protective barriers. The laboratory test segment dominated the market.

The laboratory testing segment dominated the market

By testing location, the laboratory testing segment made up the lion's share in 2020, contributing over four-fifths of the market, as the majority of diagnostic testing cases take place in laboratories. However, the point-of-care test segment is expected to record the highest CAGR of 6.3% between 2021 and 2030, due to untapped markets in developing countries.

𝐁𝐮𝐲 𝐍𝐨𝐰:
https://www.alliedmarketresearch.com/checkout-final/70b6c43e5d16707aad5dffad6d76397e

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.